Marex Group’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39,300
Closed -$556K 1030
2025
Q4
$556K Buy
+39,300
New +$569K ﹤0.01% 535
2024
Q3
Sell
-15,000
Closed -$246K 632
2024
Q2
$246K Buy
+15,000
New +$241K 0.01% 462

Other funds holding BCAT

Marex Group's BCAT Position: Q1 2026 in Review

Marex Group sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026, closing a stake of 39,300 shares — an estimated $556K sold.

Marex Group first reported a position in BCAT in Q2 2024 and held it in 2 quarters. The position peaked at $556K in Q4 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • Marex Group reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2026 after selling out during the quarter.
  • Marex Group sold 39,300 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $556K.
  • Marex Group first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and held it in 2 quarters.
  • Marex Group's BlackRock Capital Allocation Term Trust position peaked at $556K in Q4 2025.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.